Klinická biochémia - nové trendy Oxidačný stres vo …...Klinická biochémia - nové trendy...
Transcript of Klinická biochémia - nové trendy Oxidačný stres vo …...Klinická biochémia - nové trendy...
Klinickaacute biocheacutemia -
noveacute trendy
Oxidačnyacute stres vo fyzioloacutegii a v patogeneacuteze niektoryacutech ochoreniacute
(Ako ho rozpoznať a ako sa proti nemu braacuteniť)
1 časť
Povinne voliteľnyacute predmet pre študentov doktorandskeacuteho štuacutedia 201718
Voľneacute radikaacutely
Vznik života na zemi
Deštrukčneacute laacutetky uacutečinneacute pri zaacuteniku živyacutech organizmov
Pred35 miliardami rokov
Voľneacute radikaacutely
Primitiacutevne molekuly Dedičneacute zmeny
Protobunky Odumreteacute bunky
Vyacuteživa
ŽIVOT
Voľneacute radikaacutely
O2 gt 1AminokyselinyNukleotidy
Naacutehodneacute zmeny v protobunkaacutech
Pred35 miliardami rokov
Voľneacute radikaacutely
Primitiacutevne molekuly Dedičneacute zmeny
Protobunky Odumreteacute bunky
Vyacuteživa
ŽIVOT
Voľneacute radikaacutely
O2 gt 1AminokyselinyNukleotidy
Naacutehodneacute zmeny v protobunkaacutech
RADIKAacuteL
jest shluk prvků chemickyacutech kteryacutež zesloučeniny chemickeacute do jineacute sloučeninypřenaacutešeti umiacuteme a jenž maacute určitou sytivostchemickou vyplyacutevajiacuteciacute z valence prvků
Sudomocneacute radikaacutely jsou u volneacutem stavuschopny existence radikaacutelů lichomocnyacutechisolovati nelze jakmile se ze sloučeninyvybaviacute ihned spolu se slučujiacute
Ottův SLOVNIacuteK NAUČNYacute dvacaacutetyacute paacutetyacute diacutel 1904
Odvodeneacute od dusiacuteka
bullnitroxid (NO)bullnitroperoxid (NOO)
bullperoxynitritovyacute anioacuten (ONOO-)
Odvodeneacute od kysliacuteka
bullsuperoxid (O2-)
bullhydroxylovyacute radikaacutel (HO)
bullsingletovyacute kysliacutek (1O2)
bullperoxid vodiacuteka (H2O2)
Voľneacute radikaacutely a ROS
Tvorba superoxidoveacuteho anioacutenoveacuteho radikaacutelu (superoxidu)
+
O2 + elektroacuten O2-redukcia
Štvorelektroacutenovaacute redukcia kysliacuteka
Kysliacutek Superoxid Peroxid vodiacuteka Hydroxylovyacute Vodaradikaacutel
Superoxiddismutaacuteza Katalaacuteza
Vzaacutejomneacute reakcie voľnyacutech radikaacutelov areaktiacutevnych metabolitov
O 2
H 2O 2bullOHO 2 bull
-O 2 H 2O
bullH R bull
RH
SOD
e bull Fe 2+Fe 3+
OH
Superoxidovyacute anioacutenovyacute radikaacutel
Peroxidvodiacuteka
Hydroxylovyacute radikaacutel
HOCl 1O 2
H 2O
Cl bull
H 2O 2
+
Kyselina chloacuterna Singletovyacute kysliacutek
NO OONO bull-HOONO
NO 2bull
Oxid dusnatyacute Peroxynitrit
Oxiddusičityacute
Kyselina dusičnaacute
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Voľneacute radikaacutely
Vznik života na zemi
Deštrukčneacute laacutetky uacutečinneacute pri zaacuteniku živyacutech organizmov
Pred35 miliardami rokov
Voľneacute radikaacutely
Primitiacutevne molekuly Dedičneacute zmeny
Protobunky Odumreteacute bunky
Vyacuteživa
ŽIVOT
Voľneacute radikaacutely
O2 gt 1AminokyselinyNukleotidy
Naacutehodneacute zmeny v protobunkaacutech
Pred35 miliardami rokov
Voľneacute radikaacutely
Primitiacutevne molekuly Dedičneacute zmeny
Protobunky Odumreteacute bunky
Vyacuteživa
ŽIVOT
Voľneacute radikaacutely
O2 gt 1AminokyselinyNukleotidy
Naacutehodneacute zmeny v protobunkaacutech
RADIKAacuteL
jest shluk prvků chemickyacutech kteryacutež zesloučeniny chemickeacute do jineacute sloučeninypřenaacutešeti umiacuteme a jenž maacute určitou sytivostchemickou vyplyacutevajiacuteciacute z valence prvků
Sudomocneacute radikaacutely jsou u volneacutem stavuschopny existence radikaacutelů lichomocnyacutechisolovati nelze jakmile se ze sloučeninyvybaviacute ihned spolu se slučujiacute
Ottův SLOVNIacuteK NAUČNYacute dvacaacutetyacute paacutetyacute diacutel 1904
Odvodeneacute od dusiacuteka
bullnitroxid (NO)bullnitroperoxid (NOO)
bullperoxynitritovyacute anioacuten (ONOO-)
Odvodeneacute od kysliacuteka
bullsuperoxid (O2-)
bullhydroxylovyacute radikaacutel (HO)
bullsingletovyacute kysliacutek (1O2)
bullperoxid vodiacuteka (H2O2)
Voľneacute radikaacutely a ROS
Tvorba superoxidoveacuteho anioacutenoveacuteho radikaacutelu (superoxidu)
+
O2 + elektroacuten O2-redukcia
Štvorelektroacutenovaacute redukcia kysliacuteka
Kysliacutek Superoxid Peroxid vodiacuteka Hydroxylovyacute Vodaradikaacutel
Superoxiddismutaacuteza Katalaacuteza
Vzaacutejomneacute reakcie voľnyacutech radikaacutelov areaktiacutevnych metabolitov
O 2
H 2O 2bullOHO 2 bull
-O 2 H 2O
bullH R bull
RH
SOD
e bull Fe 2+Fe 3+
OH
Superoxidovyacute anioacutenovyacute radikaacutel
Peroxidvodiacuteka
Hydroxylovyacute radikaacutel
HOCl 1O 2
H 2O
Cl bull
H 2O 2
+
Kyselina chloacuterna Singletovyacute kysliacutek
NO OONO bull-HOONO
NO 2bull
Oxid dusnatyacute Peroxynitrit
Oxiddusičityacute
Kyselina dusičnaacute
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Pred35 miliardami rokov
Voľneacute radikaacutely
Primitiacutevne molekuly Dedičneacute zmeny
Protobunky Odumreteacute bunky
Vyacuteživa
ŽIVOT
Voľneacute radikaacutely
O2 gt 1AminokyselinyNukleotidy
Naacutehodneacute zmeny v protobunkaacutech
Pred35 miliardami rokov
Voľneacute radikaacutely
Primitiacutevne molekuly Dedičneacute zmeny
Protobunky Odumreteacute bunky
Vyacuteživa
ŽIVOT
Voľneacute radikaacutely
O2 gt 1AminokyselinyNukleotidy
Naacutehodneacute zmeny v protobunkaacutech
RADIKAacuteL
jest shluk prvků chemickyacutech kteryacutež zesloučeniny chemickeacute do jineacute sloučeninypřenaacutešeti umiacuteme a jenž maacute určitou sytivostchemickou vyplyacutevajiacuteciacute z valence prvků
Sudomocneacute radikaacutely jsou u volneacutem stavuschopny existence radikaacutelů lichomocnyacutechisolovati nelze jakmile se ze sloučeninyvybaviacute ihned spolu se slučujiacute
Ottův SLOVNIacuteK NAUČNYacute dvacaacutetyacute paacutetyacute diacutel 1904
Odvodeneacute od dusiacuteka
bullnitroxid (NO)bullnitroperoxid (NOO)
bullperoxynitritovyacute anioacuten (ONOO-)
Odvodeneacute od kysliacuteka
bullsuperoxid (O2-)
bullhydroxylovyacute radikaacutel (HO)
bullsingletovyacute kysliacutek (1O2)
bullperoxid vodiacuteka (H2O2)
Voľneacute radikaacutely a ROS
Tvorba superoxidoveacuteho anioacutenoveacuteho radikaacutelu (superoxidu)
+
O2 + elektroacuten O2-redukcia
Štvorelektroacutenovaacute redukcia kysliacuteka
Kysliacutek Superoxid Peroxid vodiacuteka Hydroxylovyacute Vodaradikaacutel
Superoxiddismutaacuteza Katalaacuteza
Vzaacutejomneacute reakcie voľnyacutech radikaacutelov areaktiacutevnych metabolitov
O 2
H 2O 2bullOHO 2 bull
-O 2 H 2O
bullH R bull
RH
SOD
e bull Fe 2+Fe 3+
OH
Superoxidovyacute anioacutenovyacute radikaacutel
Peroxidvodiacuteka
Hydroxylovyacute radikaacutel
HOCl 1O 2
H 2O
Cl bull
H 2O 2
+
Kyselina chloacuterna Singletovyacute kysliacutek
NO OONO bull-HOONO
NO 2bull
Oxid dusnatyacute Peroxynitrit
Oxiddusičityacute
Kyselina dusičnaacute
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Pred35 miliardami rokov
Voľneacute radikaacutely
Primitiacutevne molekuly Dedičneacute zmeny
Protobunky Odumreteacute bunky
Vyacuteživa
ŽIVOT
Voľneacute radikaacutely
O2 gt 1AminokyselinyNukleotidy
Naacutehodneacute zmeny v protobunkaacutech
RADIKAacuteL
jest shluk prvků chemickyacutech kteryacutež zesloučeniny chemickeacute do jineacute sloučeninypřenaacutešeti umiacuteme a jenž maacute určitou sytivostchemickou vyplyacutevajiacuteciacute z valence prvků
Sudomocneacute radikaacutely jsou u volneacutem stavuschopny existence radikaacutelů lichomocnyacutechisolovati nelze jakmile se ze sloučeninyvybaviacute ihned spolu se slučujiacute
Ottův SLOVNIacuteK NAUČNYacute dvacaacutetyacute paacutetyacute diacutel 1904
Odvodeneacute od dusiacuteka
bullnitroxid (NO)bullnitroperoxid (NOO)
bullperoxynitritovyacute anioacuten (ONOO-)
Odvodeneacute od kysliacuteka
bullsuperoxid (O2-)
bullhydroxylovyacute radikaacutel (HO)
bullsingletovyacute kysliacutek (1O2)
bullperoxid vodiacuteka (H2O2)
Voľneacute radikaacutely a ROS
Tvorba superoxidoveacuteho anioacutenoveacuteho radikaacutelu (superoxidu)
+
O2 + elektroacuten O2-redukcia
Štvorelektroacutenovaacute redukcia kysliacuteka
Kysliacutek Superoxid Peroxid vodiacuteka Hydroxylovyacute Vodaradikaacutel
Superoxiddismutaacuteza Katalaacuteza
Vzaacutejomneacute reakcie voľnyacutech radikaacutelov areaktiacutevnych metabolitov
O 2
H 2O 2bullOHO 2 bull
-O 2 H 2O
bullH R bull
RH
SOD
e bull Fe 2+Fe 3+
OH
Superoxidovyacute anioacutenovyacute radikaacutel
Peroxidvodiacuteka
Hydroxylovyacute radikaacutel
HOCl 1O 2
H 2O
Cl bull
H 2O 2
+
Kyselina chloacuterna Singletovyacute kysliacutek
NO OONO bull-HOONO
NO 2bull
Oxid dusnatyacute Peroxynitrit
Oxiddusičityacute
Kyselina dusičnaacute
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
RADIKAacuteL
jest shluk prvků chemickyacutech kteryacutež zesloučeniny chemickeacute do jineacute sloučeninypřenaacutešeti umiacuteme a jenž maacute určitou sytivostchemickou vyplyacutevajiacuteciacute z valence prvků
Sudomocneacute radikaacutely jsou u volneacutem stavuschopny existence radikaacutelů lichomocnyacutechisolovati nelze jakmile se ze sloučeninyvybaviacute ihned spolu se slučujiacute
Ottův SLOVNIacuteK NAUČNYacute dvacaacutetyacute paacutetyacute diacutel 1904
Odvodeneacute od dusiacuteka
bullnitroxid (NO)bullnitroperoxid (NOO)
bullperoxynitritovyacute anioacuten (ONOO-)
Odvodeneacute od kysliacuteka
bullsuperoxid (O2-)
bullhydroxylovyacute radikaacutel (HO)
bullsingletovyacute kysliacutek (1O2)
bullperoxid vodiacuteka (H2O2)
Voľneacute radikaacutely a ROS
Tvorba superoxidoveacuteho anioacutenoveacuteho radikaacutelu (superoxidu)
+
O2 + elektroacuten O2-redukcia
Štvorelektroacutenovaacute redukcia kysliacuteka
Kysliacutek Superoxid Peroxid vodiacuteka Hydroxylovyacute Vodaradikaacutel
Superoxiddismutaacuteza Katalaacuteza
Vzaacutejomneacute reakcie voľnyacutech radikaacutelov areaktiacutevnych metabolitov
O 2
H 2O 2bullOHO 2 bull
-O 2 H 2O
bullH R bull
RH
SOD
e bull Fe 2+Fe 3+
OH
Superoxidovyacute anioacutenovyacute radikaacutel
Peroxidvodiacuteka
Hydroxylovyacute radikaacutel
HOCl 1O 2
H 2O
Cl bull
H 2O 2
+
Kyselina chloacuterna Singletovyacute kysliacutek
NO OONO bull-HOONO
NO 2bull
Oxid dusnatyacute Peroxynitrit
Oxiddusičityacute
Kyselina dusičnaacute
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Odvodeneacute od dusiacuteka
bullnitroxid (NO)bullnitroperoxid (NOO)
bullperoxynitritovyacute anioacuten (ONOO-)
Odvodeneacute od kysliacuteka
bullsuperoxid (O2-)
bullhydroxylovyacute radikaacutel (HO)
bullsingletovyacute kysliacutek (1O2)
bullperoxid vodiacuteka (H2O2)
Voľneacute radikaacutely a ROS
Tvorba superoxidoveacuteho anioacutenoveacuteho radikaacutelu (superoxidu)
+
O2 + elektroacuten O2-redukcia
Štvorelektroacutenovaacute redukcia kysliacuteka
Kysliacutek Superoxid Peroxid vodiacuteka Hydroxylovyacute Vodaradikaacutel
Superoxiddismutaacuteza Katalaacuteza
Vzaacutejomneacute reakcie voľnyacutech radikaacutelov areaktiacutevnych metabolitov
O 2
H 2O 2bullOHO 2 bull
-O 2 H 2O
bullH R bull
RH
SOD
e bull Fe 2+Fe 3+
OH
Superoxidovyacute anioacutenovyacute radikaacutel
Peroxidvodiacuteka
Hydroxylovyacute radikaacutel
HOCl 1O 2
H 2O
Cl bull
H 2O 2
+
Kyselina chloacuterna Singletovyacute kysliacutek
NO OONO bull-HOONO
NO 2bull
Oxid dusnatyacute Peroxynitrit
Oxiddusičityacute
Kyselina dusičnaacute
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Tvorba superoxidoveacuteho anioacutenoveacuteho radikaacutelu (superoxidu)
+
O2 + elektroacuten O2-redukcia
Štvorelektroacutenovaacute redukcia kysliacuteka
Kysliacutek Superoxid Peroxid vodiacuteka Hydroxylovyacute Vodaradikaacutel
Superoxiddismutaacuteza Katalaacuteza
Vzaacutejomneacute reakcie voľnyacutech radikaacutelov areaktiacutevnych metabolitov
O 2
H 2O 2bullOHO 2 bull
-O 2 H 2O
bullH R bull
RH
SOD
e bull Fe 2+Fe 3+
OH
Superoxidovyacute anioacutenovyacute radikaacutel
Peroxidvodiacuteka
Hydroxylovyacute radikaacutel
HOCl 1O 2
H 2O
Cl bull
H 2O 2
+
Kyselina chloacuterna Singletovyacute kysliacutek
NO OONO bull-HOONO
NO 2bull
Oxid dusnatyacute Peroxynitrit
Oxiddusičityacute
Kyselina dusičnaacute
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Štvorelektroacutenovaacute redukcia kysliacuteka
Kysliacutek Superoxid Peroxid vodiacuteka Hydroxylovyacute Vodaradikaacutel
Superoxiddismutaacuteza Katalaacuteza
Vzaacutejomneacute reakcie voľnyacutech radikaacutelov areaktiacutevnych metabolitov
O 2
H 2O 2bullOHO 2 bull
-O 2 H 2O
bullH R bull
RH
SOD
e bull Fe 2+Fe 3+
OH
Superoxidovyacute anioacutenovyacute radikaacutel
Peroxidvodiacuteka
Hydroxylovyacute radikaacutel
HOCl 1O 2
H 2O
Cl bull
H 2O 2
+
Kyselina chloacuterna Singletovyacute kysliacutek
NO OONO bull-HOONO
NO 2bull
Oxid dusnatyacute Peroxynitrit
Oxiddusičityacute
Kyselina dusičnaacute
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Vzaacutejomneacute reakcie voľnyacutech radikaacutelov areaktiacutevnych metabolitov
O 2
H 2O 2bullOHO 2 bull
-O 2 H 2O
bullH R bull
RH
SOD
e bull Fe 2+Fe 3+
OH
Superoxidovyacute anioacutenovyacute radikaacutel
Peroxidvodiacuteka
Hydroxylovyacute radikaacutel
HOCl 1O 2
H 2O
Cl bull
H 2O 2
+
Kyselina chloacuterna Singletovyacute kysliacutek
NO OONO bull-HOONO
NO 2bull
Oxid dusnatyacute Peroxynitrit
Oxiddusičityacute
Kyselina dusičnaacute
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Dvojakaacute uacuteloha voľnyacutech radikaacutelov a ich reaktiacutevnych
metabolitov
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Voľneacute radikaacutely ndash negatiacutevna funkcia
bull ak sa tvoria vo veľkom množstve
bull ak sa tvoria na nespraacutevnom miest
bull ak suacute v bliacutezkosti ioacuteny prechodnyacutech prvkov
bull ak zlyhaacute ochrana organizmu
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Voľneacute radikaacutelyRM ndash pozitiacutevna funkcia
bull Reprodukcia (O2- H2O2)
bull Fagocytoacuteza (O2- H2O2 OH )
bull Signaacutelne funkcie
bull Hydroxylačneacute karboxylačneacute peroxidačneacute
reakcie (hydroxylaacutecia proliacutenu lyziacutenu (- Fe(II)-O2 Fe(III)-O2- )
a redukcia ribonukleotidu(ribonukleoziddifosfaacutetreduktaacuteza RR-S )
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
VONKAJŠIE ZDROJE VR a RMK
bull Cigaretovyacute dymbull Znečistenie životneacuteho
prostrediabull Radiaacuteciabull Chemoterapeutikaacutebull Ozoacutenbull Niektoreacute pesticiacutedy
organickeacute rozpuacutešťadlaacute
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
VNUacuteTORNEacute ZDROJE VR a ROS
bull Prenos elektroacutenov v dyacutechacom reťazci mitochondriiacute
bull Metabolizmus kyseliny arachidoacutenovejbull Reakcie cytochroacutemu P450bull Systeacutemy middotNO syntaacutezybull Autooxidaacutecia katecholamiacutenovbull Zaacutepalbull Reakcie zahŕňajuacutece ioacuteny prechodnyacutech prvkov
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Ďuračkovaacute (1998) Slovak Academic Press
(Fe-S)
FMN
KOMPLEX I NADH-dehydrogenaacuteza
KOMPLEX IIsukcinaacutetdehydrogenaacuteza
KOMPLEX IIIubichinol-cytochroacutem c -reduktaacuteza
KOMPLEX IVcytochroacutem c-oxidaacuteza
KOMPLEX V ATP-syntetaacuteza
Q
NADHGlutamaacutetPyruvaacutet3-hydroxybutyraacutet
(Fe-S)
FAD
Sukcinaacutet
(Fe-S)
2Hb
c1
C
H+
a - Cu
a3 - Cu
O2H 2O 12
ADP ATP
Vnuacutetromitochondriovyacute priestor
Vnuacutetornaacutemitochondriovaacutemembraacutena
Cytoplazma
Q
ProteiacutenmtDNALipid
O2-
O2
H 2O2 OH
QH
QH2
Fe(II)
Fe(III)
MnSOD
OH
Fe2+
O2O2-
O2O2-
O2O2-
Tvorba voľnyacutech radikaacutelov v dyacutechacom reťazci mitochondriiacute
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Ak nie je dostato čnaacute ochrana -ROS uacutečinkujuacute v mitochondriaacutech aj mimo ne
Mn-SOD
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Schematic representation of a phagocyte engulfing a microbe into a phagocyte vacuole
The NADPH oxidaseis selectively activated in the wall of the vacuole generating superoxide and hydrogen peroxide in the vacuolar lumen
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Tvorba superoxidupočas fagocytoacutezy
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Tvorba O2-
NADPH-oxidaacutezou
v membraacutene
neutrofilu
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
NADPH
NADP+
FAD BH4
FMN Fe
NOS
L- arginineO2
L -citrulline
NO
XOxantine uric acid
O2 H2O2
Xanthine oxidase
Sup
erox
ide-
gene
ratin
g en
zym
esA
ntio
xida
nt e
nzym
es
AA
PLA2
Lipoxygenase
1215-LO
COO
H
5-LO
proinflammatory LTs
O2-
O2
p67rac
NOX
1 4p22
NADPH NADP+
NAD(P)H oxidase
p47
e-
e- e- e- e-
Mitochondria
NADH
NAD+
H2O
O2
I II IVII
Q C ATP
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
NOSkatalyzuje tvorbu nitroxidu
Ko-faktory NOS
bull BH4
bullHem
bullFMN
bullFAD
bullkalmoduliacuten
eNOS
nNOS
iNOS
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
eNOS catalyses NO formation
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
The Nobel Prize in Physiology or Medicine 1998for their discoveries concerning nitric oxide as a signalling molecule in
the cardiovascular system
Robert F Furchgott Louis J Ignarro Ferid Murad
1916 ndash 2009 1941 - 1936 ndash
USA USA USA
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Biologickeacute uacutečinky NO
NO-syntaacuteza
NOO2
L-arginiacuten L-citruliacuten
Regulačneacute(fmol-pmol)
NeurotransmiterPrenos nervoveacuteho vzruchu
Cievny tonusOvplyvnenie imunitnyacutech
mechanizmovPermeabilita cievnej steny
ŠkodliveacuteProoxidačneacute (nnmol)
Inhibiacutecia enzyacutemovPoškodenie DNA lipidov proteiacutenovZniacuteženie antioxidačnej kapacityZvyacutešenie citlivosti voči radiaaacutecii
alkylačnyacutem činidlaacutemtoxickyacutem kovom
H2NCH
COOH
(CH2)3NHC
H2N NH
H2NCH
COOH
(CH2)3NHC
H2N O
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Pozitiacutevna funkcia NO
cGMP
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Toxickosť reakcie superoxidu s NO
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Proposed mechanism for ischemia-induced formation of reactive oxygen species
Balaraman Kalyanaraman
httpdxdoiorg101016jredox201301014
Uric acid
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
HO
HO
CH CH2 NH2
OH
NoradrenaliacutenFMN
NH3
FMNH2
O2H2O2
H2O
HO
HO
CH COH
O
H
H2O
H2O2
O2 FMNH2
FMN
MAO
MAO
HO
HO
CH COH
O
OH
Kyselina 34-dihydroxymandlovaacute
COMT
S-adenozylmetioniacuten
O
HO
CH COH
O
OHH3C
Kyselina vanilmandlovaacute
Obr Tvorba peroxidu vodiacuteka počas degradaacutecie katecholamiacutenov MAO-monoaminooxidaacuteza COMT-katechol-O-metyltransferaacuteza
34-dihydroxyfenylglykoaldehyd
Tvorba H2O2
pri degradaacutecii
katecholamiacutenov
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Fentonova a Haber-Weissova reakcia
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
PROTEIacuteNOV
DNA
LIPIDOV
POŠKODENIE
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Lipoperoxidaacutecia
ROS
(Fe2+ Cu+)MDA
4HNE
pentaacuten hexaacuten
ProteiacutenyNH2
SH
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
zosieťovanie proteiacutenov
H2N-apoA-I pre HDL
PUFA
FLCE
LDL
PUFA
H
O2
PUFA
O2
PUFA
O-O
PUFA
OOH
Hydrolipoperoxid
PUFA
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
LipoperoxidaacuteciaR 1
R 2Fosfolipid LH
Alkylovyacute radikaacutel
Konjugovanyacute dieacutenalkyloveacuteho radikaacutelu
Peroxylovyacute radikaacutel
O O
malondialdehyd(MDA)
R 1
R 2
OOH
LOOH
Peroxylovyacute radikaacutelAlkoxylovyacute radikaacutel
Hydroperoxid
AlkanalyAlkenaly(4-HNE MDA)
štiepenie
R 2O
H
Alkenylovyacute(alebo alkanylovyacute)radikaacutel Alkenal
modifikaacutecia biomolekuacutel
O 2
Komplex Fe(II) Komplex Fe(III)
R
RH
L
L
LOO
R 1
R 2
R 1
R 2
R 1
R 2
OO
RH
R
R 2
O O
R 1
R 1
R 2
O
LO
R 1
R 2
OO
LOO
R 1
RH
R
Alkeacuteny
Alkaacutenypľuacuteca
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
bullminus bull bullO2 OH R
trans-hydroxynonenal
MDA
8-isoprostaacuten
Produkty oxidačneacuteho poškodenia kyseliny arachidoacutenovej
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Zložky lipidovMastneacute kyseliny
Nasyacuteteneacute (viac zastuacutepeneacute v tukoch)(kys palmitovaacute kys stearovaacute)ndash stabilnejšie ndash maacutelo citliveacute na oxidaacuteciundash ťažšie straviteľneacute
Nenasyacuteteneacute (obsahujuacute dvojituacute vaumlzbu)(viac zastuacutepeneacute v olejoch)
(kys olejovaacute kys linolovaacute kys linoleacutenovaacute) ndash menej staacutelendash ľahšie straviteľneacute ndash citliveacute na oxidaacuteciu (voľnyacutemi radikaacutelmi)
okrem kyseliny olejovej (C181)
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Vyacuteznam zloženia PUFAANTIOXIDA ČNE Kyselina olejovaacute C181 (cis)
Nasyacuteteneacute vyššie karboxyl kyseliny
PROOXIDAČNE ndash nenasyacuteteneacute
Omega ndash 3 Rybie olejekyselina linoleacutenovaacute C183
kyselina dokozahexaeacutenovaacute C226
kyselina eikozapentaeacutenovaacute C205
Omega ndash 6 Rastlinneacute olejekyselina linolovaacute C182
kyselina archidoacutenovaacute C204
COOH
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Porucha integrity bunky
Rakovina
Kardiovaskulaacuterne ochorenia
Metabolickyacute syndroacutem
Diabetes mellitus
Psychickeacute poruchy
Porucha v zloženiacute
membraacuteny
Bunkovaacute membraacutena
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Synteacuteza PUFAs z kys linolovej LA C182 ω-6 akys α-linoleacutenovej ALA C183 ω-3
Kys linolovaacute LA C182 ω-6
Kys dokozatetraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
∆4 desaturaacuteza
elongaacuteza
Kys linoleacutenovaacute ALA C183 ω-3
Kys arachidoacutenovaacute AA C204 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
581114COOH20
Kysstearidoacutenovaacute C184
Kys eikozatetraeacutenovaacute C204
Kys eikozapentaeacutenovaacute EPA C205 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
elongaacuteza
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆4 desaturaacuteza
elongaacuteza
37
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Synteacuteza kys linolovej LA C182 ω-6 a kys α-linoleacutenovej ALA C183 ω-3
Kys linoleacutenovaacute ALA C183 ω-3Kys linolovaacute LA C182 ω-6
Kys λ -linoleacutenovaacute GLA
Kys dihomo-λ-linoleacutenovaacute DGLA
Kys arachidoacutenovaacute AA C204 ω-6
Kys dokozatatraeacutenovaacute C224
Kys dokozapentaeacutenovaacute C225
Kysstearidoacutenovaacute C184
Kys eikozatatraeacutenovaacute
Kys eikozapentaeacutenovaacute EPA C203 ω-3
Kys dokozapentaeacutenovaacute C225 ω-3
Kys dokozahexaeacutenovaacute DHA C226 ω-3
∆6 desaturaacuteza
∆5 desaturaacuteza
∆4 desaturaacuteza
elongaacuteza
elongaacuteza
COX2 5-LOXTvorba pro-zaacutepaľovyacutech PG2
TXA2 LTB4
COX2 Tvorba proti-zaacutepaľovyacutech PG1
a TXA1COX2 5-LOX
Tvorba proti-zaacutepaľovyacutech PG3 TXA3 LT5
38
NeuroprostaacutenyResolviacuteny ndash blokujuacute tvorbu
prostanoidov
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
PGF1
PGF1
α
PGF2
PGF2
α
PGF3
PGF3
α
DGLA
EPA
AA
Pro-zaacutepaloveacute
a
Proti-zaacutepaloveacute
eikozaacutenoidy
39
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
POTRAVAALALA
COX2 LOX
AA
PG2 TX2 LT4
PhL A2
Kompetiacuteciacutea zabudovania do membraacuteny
PhL A2
EPA menej DHA
COX2 LOX
PG3 TX3 LT5
40
GLA
DGLA
AA
D6D
D5DEPA
D6DD5D
D4DDHA
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Bioaktiacutevneprodukty
PMNL ndashchemotaxia
Trombocyty - P-selektin
expresia-TrombocytLeuko
cyt interakcia
Isch- rep poškodenie orgaacutenov
- PMNL-Transmigraacuteci
a cez endotel
- Eferocyoacuteza apoptickyacutech
PMNL
COX2
41
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Fyzikaacutelny vplyv rocircznych MK na funkciu buniek
Fluidita - tekutosť
Ohyacutebanie Rotaacutecia Bočnaacute difuacutezia Poskakovanie Obaacutetenie sa
(flexion) (lateral diffusion) (bobbing)
42
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Spektrum mastnyacutech kyseliacuten v rastlinnyacutech olejoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute DHA
Slnečnicovyacute 91 37 271 601 ndashndashndash- 05
Olivovyacutepanenskyacute
198 83 512 176 28 ndashndashndash
Soacutejovyacute 130 31 250 487 101 ndashndashndash
Repkovyacutepanenskyacute
71 12 513 263 139 ndashndashndash
Ľanovyacutepanenskyacute
78 24 227 404 267 ndashndashndash
Mandľovyacute 77 20 522 382 05 07
Nasyacuteteneacute Nenasyacuteteneacute
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Spektrum mastnyacutech kyseliacuten v tukoch
palmitovaacute steaacuterovaacute olejovaacute linolovaacute linoleacutenovaacute Arachidoacute-novaacute
EPA DHA
Rybiacute tuk 156 52 365 115 119 68 61 63
Kačacia masť
243 79 502 166 23 01 ndashndash- ndashndash-
Bravč masť
257 178 428 108 23 06 ndashndash-- ndashndash-
Bravč masť mangalica
263 139 479 93 23 06 ndashndash- ndashndash-
Olivovyacute olej
198 83 512 176 28 ndashndashndash ndashndash- ndashndash-
Nasyacuteteneacute Nenasyacuteteneacute
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
ZAacuteVER bull Zmena stravovania (Western nutrition) ndash naacuterast KVO a psychickyacutech
poruacutechbull KVO a psychickeacute ochoreniandash viacereacute spoločneacute patofyzilogickeacute znaky
- tvorba pro-zaacutepalovyacutech cytokiacutenov- endotelovaacute dysfunkcia- tvorba HCy- abnormality v prietoku krvi (u dpresie ndash hypoperfuacutezia v limbickom
systeacuteme a prefrontal cortex- utilizaacutecia glukoacutezy v niektoryacutech oblastiach mozgu
Spoločnyacute menovateľ ndash zmena konzumaacutecie a pomeru omega-6 ku omega-3 MK
Suplementaacutecia omega-3 MK ndash bezpečneacute jednoducheacute relatiacutevne lacneacute45
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Pozor ndash fajčenie inhibuje inkorporaacuteciu omega-3 do erytrocytov
Suplementy omega-3 MK (Raatz a kol 2009)
- emulzia ndash lepšie sa absorbujuacute omega-3 MK lepšiacute priacutestup lipaacutez mocircže sa upraviť chuť aditiacutevami
- tobolky kapsulky- triacylglyceroly z rybieho oleja ndash polovičneacute využitie - ako u emulzie
Nežiaduce uacutečinky dlhodobeacute vysokeacute daacutevkybull dyskomfort GIT ndash riedka stolica hnačka nevoľnosť zvracanie
nechutenstvobull krvaacutecanie do GITu ndash odporuacuteča sa 3-7 dniacute pred operaacuteciou užiacutevanie v
vynechaťbull nedostatok vitamiacutenu E ndash doplnkovaacute suplementaacuteciabull užiacutevať s jedlom
46
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
V suacutečasnosti sa odporuacutečaAmerickaacute Psychiatrickaacute SpoločnosťDennyacute priacutejem omegandash3 = minimaacutelne 1gFDA (Food and Drug Administration)Dennaacute daacutevka omega-3 dospelyacutem - 3 g European Food Safety AuthorityDennaacute daacutevka omega-3 (EPA+DHA+DPA) pre dospelyacutech ndash 5 g
Majuacute status GRAS
pre dospelyacutech
Minimaacutelne daacutevky omega-3 MK (Global Recommendations for EPA and DHA Intake -1642014)Dospelyacute Euroacutepan ndash 250 mg EPA+DHA denneTehotneacute a dojčiace ženy ndash 100-200 mg DHA denne Deti 7-24 mesiacov ndash 100 mg DHA denneDeti 2-18 rokov ndash 250 mg EPA+DHA denne
47
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Pomer omegandash6 omegandash3 = 2 1 ndash optimumNemal by prekročiť 5 1 Lepšie je omega-6 zniacutežiť ako omega-3 zvyacutešiť
Kardioloacutegovia odporuacutečajuacute pre omega-3 pomer DHA EPA = 2 1
Sledovať informaacutecie na priacutebalovom letaacuteku
Pri psychickyacutech poruchaacutechndash EPADHA = 6040
Odporuacutečania
Sinopoulos 2002 Grosso a kol 2014 Farouuqui et al 2009 Gow a Hibbeln 2014Zaacutevery WHO FDA EFSA a inyacutech
Tyacuteždenne 2 ndash 3 jedlaacute z ryacuteb
48
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Oxidačneacute poškodenie proteiacutenov
PRIMAacuteRNEbull reakcie katalyzovaneacute ioacutenmi prechodnyacutech prvkovbull radiaacutecia ozoacuten bull oxidy dusiacuteka bull HOCl
SEKUNDAacuteRNEProteiacuteny suacute modifikovaneacute produktmi oxidaacutecie inyacutech molekuacutel (vaumlzba 4HNE a MDA na -NH2 a -SH skupiny)
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
donor elektroacutenov
H2O2
e-
Fe(III)
Fe(II)
H2OH+
e-2 CH2NH2
CH2NH2
OH-
Fe(III)proteiacuten
proteiacuten
H2O
NH3OH -
proteaacutezy
Aminokyseliny Peptidy
CH2NH2
Fe(II)proteiacuten C OHproteiacuten
CH NH
OH -
Fe(II)proteiacuten
CHNH2
OH-
Fe(III)proteiacuten
HO
H+O22
Tvorba karbonylov proteiacutenov katalyzovanaacute ioacutenmi Fe
donor elektroacutenov
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
OXIDAČNYacute ZAacuteSAH DNA
Ľudskaacute bunka metabolizuje denne 1012 molekuacutel O2
Tvoriacute 3x109 molekuacutel H2O2
Oxidačne sa zasahuje 2x105
nukleotidovbunkudeň
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
bullOxidačneacute poškodenie puriacutenovyacutech a
pyrimidiacutenovyacutech zaacutesad
bull Oxidačneacute poškodenie deoxyriboacutezovej
jednotky (C4-d riboacutezy)
bull Jednovlaacuteknoveacute alebo dvojvlaacuteknoveacute
zlomy DNA
OXIDAČNEacute POŠKODENIE DNA
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Hlavneacute produkty oxidačnho poškodenia DNA
Fapy ndash 24-diamiacuteno-5-formamido-6-oxopyrimidiacuten
HN HNN O
O
NH2
O
N
N OHNH2
N
N
HO
NH2
OH
H
HN
NH
O
O
CH3
OH
OH
H
FapyAde 8-OH-Gua
56-OH-Tym
H
H
5-OH-Cyt
N NNH2
H
45-OH-Tym
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
8-oxo-dG10 G Lymphocytes8-oxo-dG106G Lymphocytes
HPLC HPLCLaboratory Country n mean SE
2 Italy 16 451 1004 Belgium11 360 0675 Slovakia 17 651 0466 Slovakia 20 665 06413 England 3 020 02014 Denmark 20 425 03228 Denmark 17 589 07415 Sweden 16 124 01016 Poland 20 423 03521 Spain 16 051 00321 Spain 16 030 001
Results of ESCODD project 5FP EU Collins et al ABB 423 57-65 2004
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
Mutagenesis of 8-oxo-dG
-G -OxodGC- -OxodG A-C-C-
OxoG
C-
A-
dTTP
A- -TPool of mutant
DNA
ROS
OxodG rotates into syn
dATP
DNA-ligase
hOgg1
endonuclease
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom
0
20
40
60
80
100
120
DS BA NM
Regioacuteny Slovenska
Sum
a po
škod
enia
Oxidačneacute poškodenie DNA u detiacute (10 ndash 13 rokov) v rocircznych regioacutenoch Slovenska (n = 18-20)
DS ndash Dunajskaacute Streda BA = Bratislava NM = Noveacute Mesto n Vaacutehom